National breast cancer audit: Overview of invasive breast cancer in New Zealand

New Zealand Medical Journal

Volumn 125, Issue 1359, 2012, Pages 8-

  Ooi, Corinne Wei Leng ^a   Campbell, Ian D ^b   Kollias, James ^c   de Silva, Primali ^d  

^a Waikato District Hospital Hamilton   (Australia)

^b Waikato Breast Care Centre   (New Zealand)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

^d ROYAL AUSTRALASIAN COLLEGE OF SURGEONS   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; HORMONE RECEPTOR; TAMOXIFEN;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SCREENING; FEMALE; HIGH RISK BEHAVIOR; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL AUDIT; NEW ZEALAND; PATIENT REFERRAL; PRACTICE GUIDELINE; SENTINEL LYMPH NODE BIOPSY; TUMOR ABLATION;

EID: 84865013467     PISSN: 00288446     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Boult M, Cuncins-Hearn A, Tyson S, et al. National Breast Cancer Audit: Establishing a Web-Based Data System. Aust. N.Z. J. Surg. 2005;75:844-847
2. Breast Screen Aotearoa, Ministry of Health 2007, http://www.breastcancer.org.nz/screen.htm
3. http://www.moh.govt.nz/moh.nsf/indexmh/dataandstatistics-collections-nzcr
4. Breastscreen Aotearoa Independent Monitoring Report: Screening and assessment report of women attending BSA (Women screened July 2007 to June 2009) (draft 5, May 2010). Dr Andrew Page, School of Population Health, University of Queensland
5. Personal Communication, Professor Richard Taylor, School of Public Health and Community Medicine, University of New South Wales, 2010
6. Cuncins-Hearn A, Boult M, Babidge W, et al. National Breast Cancer Audit: Overview of Invasive Breast Cancer Management, Aust N Z J Surg. 2006; 76: 745-750
7. Turnbull L, Brown S, Harvey I, et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. The Lancet Vol 375 February 13,2010: 563-571
8. Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial. Gill G; SNAC Trial Group of the Royal Australasian College of Surgeons (RACS) and NHMRC Clinical Trials Centre. Ann Surg Oncol. 2009 Feb;16(2):266-75. Epub 2008 Dec 3.
9. National Breast and Ovarian Cancer Centre. Clinical Practise Guidelines for the Management of Early Breast Cancer, 2nd edn. Australian Government. National Health and Medical Research Council (NHMRC) publication, 2001.
10. New Zealand Guidelines Group. 2009. Management of Early Breast Cancer-Evidence-based Best Practice Guidelines. Wellington: New Zealand Guidelines Group, http://www.nzgg.org.nz/guidelines/dsp_guideline_popup.cfm?guidelineID=157
11. Yu KD, Di GH, Wu J, et al. Breast cancer patients with estrogen receptornegative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment. J Cancer Res Clin Oncol. 2008 Dec;134(12):1347-54. Epub 2008 May 17.
12. Bardou VJ, Arpino G, Elledge RM, et al. Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases. J Clin Oncol. 2003 May 15;21(10):1973-9.